Avalo Therapeutics Inc
NASDAQ:AVTX
Income Statement
Earnings Waterfall
Avalo Therapeutics Inc
Revenue
|
1.9m
USD
|
Cost of Revenue
|
-1.3m
USD
|
Gross Profit
|
640k
USD
|
Operating Expenses
|
-24.1m
USD
|
Operating Income
|
-23.4m
USD
|
Other Expenses
|
-8.1m
USD
|
Net Income
|
-31.5m
USD
|
Income Statement
Avalo Therapeutics Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+49%
|
1
+19%
|
2
+33%
|
1
-32%
|
26
+2 377%
|
28
+8%
|
32
+15%
|
37
+15%
|
16
-57%
|
7
-55%
|
5
-27%
|
2
-66%
|
(0)
N/A
|
7
N/A
|
7
+3%
|
7
-1%
|
6
-16%
|
7
+16%
|
4
-34%
|
6
+46%
|
7
+4%
|
5
-19%
|
6
+13%
|
4
-38%
|
17
+361%
|
18
+4%
|
17
-4%
|
17
-2%
|
2
-87%
|
2
-15%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(6)
|
(3)
|
(3)
|
(0)
|
3
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
27
N/A
|
5
-81%
|
9
+64%
|
10
+11%
|
4
-60%
|
2
-48%
|
1
-24%
|
3
+74%
|
7
+182%
|
8
+12%
|
7
-20%
|
6
-16%
|
6
+16%
|
4
-36%
|
6
+49%
|
6
-10%
|
4
-29%
|
4
+1%
|
0
-96%
|
14
+9 320%
|
15
+3%
|
14
-4%
|
15
+3%
|
0
-99%
|
1
+433%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(10)
|
(16)
|
(17)
|
(16)
|
(15)
|
(11)
|
(11)
|
(13)
|
(15)
|
(19)
|
(17)
|
(15)
|
(12)
|
(9)
|
(13)
|
(18)
|
(24)
|
(27)
|
(19)
|
(18)
|
(16)
|
(15)
|
(23)
|
(25)
|
(33)
|
(42)
|
(54)
|
(76)
|
(83)
|
(86)
|
(86)
|
(76)
|
(67)
|
(61)
|
(52)
|
(39)
|
(35)
|
(29)
|
(24)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(6)
|
(7)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(9)
|
(12)
|
(16)
|
(18)
|
(11)
|
(10)
|
(7)
|
(6)
|
(12)
|
(12)
|
(16)
|
(18)
|
(20)
|
(22)
|
(22)
|
(23)
|
(25)
|
(31)
|
(26)
|
(24)
|
(21)
|
(12)
|
(11)
|
(11)
|
(10)
|
|
Research & Development |
(7)
|
(12)
|
(12)
|
(11)
|
(10)
|
(7)
|
(7)
|
(7)
|
(8)
|
(11)
|
(10)
|
(9)
|
(7)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(8)
|
(10)
|
(11)
|
(12)
|
(13)
|
(15)
|
(22)
|
(32)
|
(53)
|
(59)
|
(61)
|
(60)
|
(44)
|
(40)
|
(37)
|
(31)
|
(28)
|
(24)
|
(18)
|
(14)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(2)
|
(1)
|
(0)
|
1
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(10)
N/A
|
(16)
-59%
|
(17)
-5%
|
(16)
+7%
|
(15)
+5%
|
(11)
+27%
|
(11)
+1%
|
(13)
-22%
|
(14)
-4%
|
(18)
-28%
|
(16)
+11%
|
(13)
+19%
|
(11)
+13%
|
17
N/A
|
14
-16%
|
12
-13%
|
10
-19%
|
(18)
N/A
|
(15)
+16%
|
(16)
-8%
|
(15)
+9%
|
(12)
+17%
|
(16)
-34%
|
(17)
-5%
|
(26)
-55%
|
(37)
-40%
|
(47)
-29%
|
(72)
-52%
|
(77)
-7%
|
(81)
-4%
|
(82)
-2%
|
(72)
+12%
|
(67)
+7%
|
(47)
+31%
|
(37)
+20%
|
(25)
+32%
|
(21)
+18%
|
(29)
-38%
|
(23)
+18%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(0)
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
1
|
0
|
7
|
5
|
5
|
5
|
(2)
|
(0)
|
(1)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(21)
|
(21)
|
(21)
|
(19)
|
0
|
0
|
(26)
|
(26)
|
(26)
|
(26)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(11)
N/A
|
(17)
-54%
|
(16)
+3%
|
(16)
+2%
|
(15)
+7%
|
(9)
+35%
|
(10)
-12%
|
(12)
-18%
|
(13)
-5%
|
(18)
-42%
|
(16)
+11%
|
(13)
+19%
|
(12)
+13%
|
17
N/A
|
14
-16%
|
12
-14%
|
8
-35%
|
(39)
N/A
|
(35)
+9%
|
(36)
-3%
|
(33)
+10%
|
(11)
+66%
|
(16)
-42%
|
(35)
-121%
|
(46)
-31%
|
(57)
-23%
|
(67)
-19%
|
(73)
-9%
|
(78)
-6%
|
(82)
-5%
|
(85)
-3%
|
(76)
+10%
|
(72)
+6%
|
(51)
+29%
|
(42)
+18%
|
(30)
+29%
|
(25)
+16%
|
(33)
-34%
|
(32)
+5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
3
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(11)
|
(17)
|
(16)
|
(16)
|
(15)
|
(9)
|
(10)
|
(12)
|
(13)
|
(18)
|
(16)
|
(13)
|
(12)
|
13
|
14
|
12
|
8
|
(35)
|
(35)
|
(37)
|
(33)
|
(11)
|
(16)
|
(33)
|
(44)
|
(54)
|
(64)
|
(73)
|
(77)
|
(81)
|
(84)
|
(76)
|
(72)
|
(51)
|
(42)
|
(30)
|
(25)
|
(33)
|
(32)
|
|
Net Income (Common) |
(11)
N/A
|
(17)
-54%
|
(4)
+79%
|
(3)
+11%
|
(2)
+37%
|
3
N/A
|
(10)
N/A
|
(12)
-18%
|
(13)
-5%
|
(18)
-42%
|
(16)
+11%
|
(13)
+19%
|
(12)
+13%
|
13
N/A
|
12
-11%
|
10
-16%
|
6
-42%
|
(38)
N/A
|
(42)
-11%
|
(45)
-9%
|
(45)
0%
|
(25)
+45%
|
(16)
+35%
|
(30)
-85%
|
(37)
-24%
|
(46)
-26%
|
(64)
-37%
|
(73)
-15%
|
(77)
-5%
|
(81)
-5%
|
(84)
-4%
|
(76)
+10%
|
(72)
+5%
|
(51)
+29%
|
(42)
+18%
|
(30)
+29%
|
(25)
+16%
|
(33)
-34%
|
(32)
+5%
|
|
EPS (Diluted) |
-14.95
N/A
|
-23.06
-54%
|
-4.9
+79%
|
-4.35
+11%
|
-2.75
+37%
|
4.41
N/A
|
-14.56
N/A
|
-17.21
-18%
|
-18.05
-5%
|
-25.31
-40%
|
-22.25
+12%
|
-15.63
+30%
|
-10.42
+33%
|
7.48
N/A
|
7.6
+2%
|
3.72
-51%
|
2.13
-43%
|
-13
N/A
|
-14.38
-11%
|
-13.16
+8%
|
-12.74
+3%
|
-6.91
+46%
|
-4.5
+35%
|
-6.62
-47%
|
-7.03
-6%
|
-7.41
-5%
|
-11.42
-54%
|
-9.89
+13%
|
-9.59
+3%
|
-9.65
-1%
|
-10.13
-5%
|
-8.05
+21%
|
-7.62
+5%
|
-5.42
+29%
|
-4.43
+18%
|
-2.52
+43%
|
-1.77
+30%
|
-0.7
+60%
|
-113.58
-16 126%
|